THE REDUCTION OF ANTITUMOR DIAZIRIDINYL BENZOQUINONES

[1] BACHUR NR, 1978, CANCER RES, V38, P1745

[2] BASRA J, 1985, ANTI-CANCER DRUG DES, V1, P45

[3] Bender J F, 1983, Invest New Drugs, V1, P71

[4] BOSANQUET AG, 1985, INVEST NEW DRUG, V3, P43

[5] BUTLER J, 1986, Journal of Free Radicals in Biology and Medicine, V2, P77, DOI 10.1016/0748-5514(86)90127-3

[6] BUTLER J, 1987, IN PRESS BR J CANCER

[7] POTENTIAL CENTRAL NERVOUS-SYSTEM ANTITUMOR AGENTS - AZIRIDINYLBENZOQUINONES .2. [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) : 1302 - 1308

[8] A PHASE-II TRIAL OF 2,5-DIAZIRIDINYL3,6-BIS(CARBOETHOXYAMINO)1,4-BENZOQUINONE(AZQ,NSC-182986) IN RECURRENT PRIMARY BRAIN-TUMORS [J]. JOURNAL OF NEURO-ONCOLOGY, 1984, 2 (01) : 13 - 17

[9] GUTIERREZ PL, 1982, CANCER TREAT REP, V66, P339

[10] EFFECTS OF ASCORBIC-ACID ON BIOLOGICALLY OBTAINED DIAZIQUONE FREE-RADICALS [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (13) : 2394 - 2397

[1] BACHUR NR, 1978, CANCER RES, V38, P1745

[2] BASRA J, 1985, ANTI-CANCER DRUG DES, V1, P45

[3] Bender J F, 1983, Invest New Drugs, V1, P71

[4] BOSANQUET AG, 1985, INVEST NEW DRUG, V3, P43

[5] BUTLER J, 1986, Journal of Free Radicals in Biology and Medicine, V2, P77, DOI 10.1016/0748-5514(86)90127-3

[6] BUTLER J, 1987, IN PRESS BR J CANCER

[7] POTENTIAL CENTRAL NERVOUS-SYSTEM ANTITUMOR AGENTS - AZIRIDINYLBENZOQUINONES .2. [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) : 1302 - 1308

[8] A PHASE-II TRIAL OF 2,5-DIAZIRIDINYL3,6-BIS(CARBOETHOXYAMINO)1,4-BENZOQUINONE(AZQ,NSC-182986) IN RECURRENT PRIMARY BRAIN-TUMORS [J]. JOURNAL OF NEURO-ONCOLOGY, 1984, 2 (01) : 13 - 17

[9] GUTIERREZ PL, 1982, CANCER TREAT REP, V66, P339

[10] EFFECTS OF ASCORBIC-ACID ON BIOLOGICALLY OBTAINED DIAZIQUONE FREE-RADICALS [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (13) : 2394 - 2397